Log In
BCIQ
Print this Print this
 

TH-1 (Thorium-227)

Also known as: TH-1 Receptor Targeted Delivery

  Manage Alerts
Collapse Summary General Information
Company Bayer AG
DescriptionThorium-227 linked to the mAb rituximab using targeted thorium conjugates (TTC) platform
Molecular Target
Mechanism of ActionRadiolabelled antibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat various cancers
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

05/16/2011

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today